48.33
price up icon0.83%   0.40
after-market アフターアワーズ: 48.95 0.62 +1.28%
loading
前日終値:
$47.93
開ける:
$48.59
24時間の取引高:
1.57M
Relative Volume:
0.74
時価総額:
$7.58B
収益:
$1.17B
当期純損益:
$150.71M
株価収益率:
51.41
EPS:
0.94
ネットキャッシュフロー:
$245.03M
1週間 パフォーマンス:
+2.13%
1か月 パフォーマンス:
-4.30%
6か月 パフォーマンス:
-35.87%
1年 パフォーマンス:
-38.51%
1日の値動き範囲:
Value
$47.93
$48.88
1週間の範囲:
Value
$46.20
$48.88
52週間の値動き範囲:
Value
$46.01
$83.62

Bio Techne Corp Stock (TECH) Company Profile

Name
名前
Bio Techne Corp
Name
セクター
Healthcare (1177)
Name
電話
(612) 379-8854
Name
住所
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Name
職員
3,100
Name
Twitter
@biotechne
Name
次回の収益日
2024-10-30
Name
最新のSEC提出書
Name
TECH's Discussions on Twitter

TECH を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
TECH
Bio Techne Corp
48.33 7.42B 1.17B 150.71M 245.03M 0.94
Biotechnology icon
ONC
Beone Medicines Ltd Adr
246.68 25.81B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
447.09 111.46B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.30 40.37M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
605.39 64.44B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
77.49 6.19B 0 -153.72M -103.81M -2.00

Bio Techne Corp Stock (TECH) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-09 ダウングレード KeyBanc Capital Markets Overweight → Sector Weight
2025-03-18 開始されました Evercore ISI Outperform
2025-02-19 ダウングレード Robert W. Baird Outperform → Neutral
2024-05-22 ダウングレード Citigroup Buy → Neutral
2024-02-08 開始されました Scotiabank Sector Outperform
2024-02-02 ダウングレード Stifel Buy → Hold
2023-12-07 開始されました UBS Buy
2023-08-28 開始されました William Blair Outperform
2023-01-10 アップグレード Wells Fargo Underweight → Equal Weight
2022-12-14 開始されました Deutsche Bank Buy
2022-12-12 アップグレード Citigroup Neutral → Buy
2022-12-07 開始されました RBC Capital Mkts Sector Perform
2022-08-25 開始されました Credit Suisse Outperform
2022-04-25 ダウングレード Wells Fargo Equal Weight → Underweight
2021-09-15 アップグレード KeyBanc Capital Markets Sector Weight → Overweight
2021-03-08 アップグレード Stephens Equal-Weight → Overweight
2021-02-23 アップグレード Stifel Hold → Buy
2021-01-25 繰り返されました The Benchmark Company Buy
2020-11-10 開始されました KeyBanc Capital Markets Sector Weight
2020-09-30 開始されました Atlantic Equities Overweight
2020-07-15 ダウングレード Stephens Overweight → Equal-Weight
2020-05-27 ダウングレード Stifel Buy → Hold
2020-05-14 開始されました The Benchmark Company Buy
2020-01-08 再開されました Stephens Overweight
2020-01-08 開始されました Wells Fargo Equal Weight
2020-01-07 開始されました Citigroup Neutral
2019-11-15 開始されました Stifel Buy
2019-07-02 アップグレード Janney Neutral → Buy
2019-01-14 アップグレード Stephens Equal-Weight → Overweight
2018-10-31 ダウングレード Craig Hallum Buy → Hold
2018-10-17 開始されました Goldman Neutral
2018-06-15 開始されました Argus Buy
2017-07-13 開始されました Wells Fargo Market Perform
2017-02-09 開始されました Citigroup Buy
2017-01-18 開始されました Deutsche Bank Buy
2016-11-10 再開されました Leerink Partners Outperform
2015-01-21 繰り返されました Robert W. Baird Outperform
2013-09-20 アップグレード Robert W. Baird Neutral → Outperform
すべてを表示

Bio Techne Corp (TECH) 最新ニュース

pulisher
08:47 AM

Is Bio-Techne Stock the Right Pick for Your Portfolio Now? - Nasdaq

08:47 AM
pulisher
07:30 AM

Bio-Techne Sets Triple Conference Appearance: William Blair, Jefferies, and Goldman Sachs in June - Stock Titan

07:30 AM
pulisher
07:00 AM

Bio-Techne to Present at Investor Conferences - PR Newswire

07:00 AM
pulisher
May 22, 2025

Bio-Techne Corp. stock underperforms Wednesday when compared to competitors - MSN

May 22, 2025
pulisher
May 22, 2025

Cetera Investment Advisers Sells 887 Shares of Bio-Techne Co. (NASDAQ:TECH) - Defense World

May 22, 2025
pulisher
May 21, 2025

Do Wall Street Analysts Like Bio-Techne Stock? - MSN

May 21, 2025
pulisher
May 20, 2025

(TECH) Technical Pivots with Risk Controls - news.stocktradersdaily.com

May 20, 2025
pulisher
May 16, 2025

Bio-Techne (NASDAQ:TECH) Rating Increased to Buy at StockNews.com - Defense World

May 16, 2025
pulisher
May 15, 2025

Ex-Dividend Reminder: Bio-Techne, First Hawaiian and Affiliated Managers Group - Nasdaq

May 15, 2025
pulisher
May 14, 2025

Wednesday Sector Laggards: Healthcare, Materials - Nasdaq

May 14, 2025
pulisher
May 14, 2025

What Makes Bio-Techne Corporation (TECH) a Compelling Addition? - Insider Monkey

May 14, 2025
pulisher
May 14, 2025

ScaleReady awards multiple G-Rex® Grants to leading investigators at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA) - Quantisnow

May 14, 2025
pulisher
May 13, 2025

Bio-Techne at BofA Securities 2025: Strategic Growth Amid Challenges By Investing.com - Investing.com Nigeria

May 13, 2025
pulisher
May 13, 2025

Bio-Techne at BofA Securities 2025: Strategic Growth Amid Challenges - Investing.com

May 13, 2025
pulisher
May 13, 2025

Transcript : Bio-Techne Corporation Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 10 - marketscreener.com

May 13, 2025
pulisher
May 12, 2025

Waters Corporation, Avantor, Azenta, Bio-Techne, and Elanco Stocks Trade Up, What You Need To Know - Yahoo Finance

May 12, 2025
pulisher
May 12, 2025

Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025 - The Malaysian Reserve

May 12, 2025
pulisher
May 12, 2025

Bio-Techne to Showcase Next-Generation Solutions for Gene and Ce - GuruFocus

May 12, 2025
pulisher
May 12, 2025

UBS Group Cuts Bio-Techne (NASDAQ:TECH) Price Target to $70.00 - Defense World

May 12, 2025
pulisher
May 10, 2025

When the Price of (TECH) Talks, People Listen - news.stocktradersdaily.com

May 10, 2025
pulisher
May 10, 2025

StockNews.com Downgrades Bio-Techne (NASDAQ:TECH) to Hold - Defense World

May 10, 2025
pulisher
May 09, 2025

Bio-Techne (TECH) Target Price Lowered to $70 by UBS Analyst | T - GuruFocus

May 09, 2025
pulisher
May 09, 2025

UBS Adjusts Price Target on Bio-Techne to $70 From $95, Maintains Buy Rating - marketscreener.com

May 09, 2025
pulisher
May 09, 2025

Bio-Techne outlines 2025 growth drivers with NIH uncertainty and strong Protein Sciences performance - MSN

May 09, 2025
pulisher
May 09, 2025

Beyond the Balance Sheet: What SWOT Reveals About Bio-Techne Corp (TECH) - GuruFocus

May 09, 2025
pulisher
May 08, 2025

Bio-Techne, Kytopen collaborate on integrated cellular engineering workflow - TipRanks

May 08, 2025
pulisher
May 08, 2025

Bio-Techne (TECH) Target Price Lowered by RBC Capital | TECH Sto - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Bio-Techne (TECH) Target Price Lowered by RBC Capital | TECH Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Benchmark Adjusts Bio-Techne Price Target to $75 From $95 - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

Bio-Techne (TECH): Benchmark Analyst Lowers Target Price but Maintains Buy Rating | TECH Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

BIO-TECHNE (TECH): Analyst Maintains Hold Rating, Lowers Price Target | TECH Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Bio-Techne to Present at the BofA Securities 2025 Health Care Conference - StreetInsider

May 08, 2025
pulisher
May 08, 2025

Kytopen and Bio-Techne Collaborate on an Integrated Cellular Eng - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing | TECH Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Bio-Techne price target lowered to $63 from $72 at RBC Capital - TipRanks

May 08, 2025
pulisher
May 08, 2025

Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing - Stock Titan

May 08, 2025
pulisher
May 08, 2025

Bio-Techne Corporation (NASDAQ:TECH) Q3 2025 Earnings Call Transcript - Insider Monkey

May 08, 2025
pulisher
May 08, 2025

Bio-Techne Third Quarter 2025 Earnings: EPS Misses Expectations - simplywall.st

May 08, 2025
pulisher
May 08, 2025

Bio-Techne to Present at the BofA Securities 2025 Health Care Conference | TECH Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

RBC Cuts Price Target on Bio-Techne to $63 From $72, Keeps Sector Perform Rating - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

Bio-Techne Corp (TECH) Q3 2025 Earnings Call Highlights: Strong Organic Growth Amid Global ... - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Bio-Techne Corp (TECH) Q3 2025 Earnings Call Highlights: Strong Organic Growth Amid Global ... By GuruFocus - Investing.com Canada

May 08, 2025
pulisher
May 08, 2025

Bio-Techne Corp (TECH) Q3 2025 Earnings Call Highlights: Strong Organic Growth Amid Global Challenges - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Bio-Techne Reports Strong Q3 2025 Revenue Growth - TipRanks

May 08, 2025
pulisher
May 07, 2025

Bio-Techne Q3 2025 Earnings Call Transcript - MarketBeat

May 07, 2025
pulisher
May 07, 2025

Bio-Techne’s Earnings Call: Growth Amid Challenges - TipRanks

May 07, 2025
pulisher
May 07, 2025

Revolutionizing Gene Therapy Protein Expression Potency Assays - Genetic Engineering and Biotechnology News

May 07, 2025
pulisher
May 07, 2025

Bio-Techne Leads Key Proteomic Reagent Markets - Morningstar

May 07, 2025
pulisher
May 07, 2025

Bio-Techne exceeds profit expectations, announces new share buyback plan - MSN

May 07, 2025
pulisher
May 07, 2025

Bio-Techne reports Q3 adjusted EPS 56c, consensus 51c - TipRanks

May 07, 2025
pulisher
May 07, 2025

Bio-Techne’s Resilience and Strong Financial Performance Justify Buy Rating Amid Market Challenges - TipRanks

May 07, 2025

Bio Techne Corp (TECH) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$1.06
price up icon 0.95%
$31.31
price up icon 3.40%
$580.95
price up icon 0.82%
$292.90
price up icon 2.57%
$4.64
price up icon 6.67%
$77.49
price up icon 4.82%
大文字化:     |  ボリューム (24 時間):